Analystreport

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) is now covered by analysts at Seaport Global Securities. They set a "buy" rating on the stock.

CONATUS PHARMACEUTICALS INC  (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations